Remix Therapeutics Compagnie réclamée
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether. These are innovative therapeutic solutions with the potential to address disease drivers at their origin. Lire la suite
Everyone is willing to help their coworkers, teach them new skills, and be fully transparent with their data and protocols.
Other Employee Reviews for Remix Therapeutics
×